Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest tumor Stories

2013-12-04 08:30:03

First FASN Anti-Tumor Candidate in Clinical Development MENLO PARK, Calif., Dec. 4, 2013 /PRNewswire/ -- 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, today announced the recent initiation of a Phase 1 clinical study of TVB-2640 in patients with advanced solid tumors. TVB-2640 is an oral, proprietary fatty acid synthase (FASN) inhibitor being evaluated for the treatment of...

2013-12-03 23:27:34

TG02 synergizes with carfilzomib in multiple myeloma models; data to be presented at ASH 2013 Annual Meeting. San Diego (PRWEB) December 03, 2013 Tragara Pharmaceuticals, Inc. today announced the initiation of a phase 1b clinical trial of TG02, in combination with the poteosome inhibitor carfilzomib (Kyprolis®), in patients with relapsed or refractory multiple myeloma. TG02 is a potent oral inhibitor of CDK9, which leads to the depletion of key survival proteins, such as Mcl-1,...

2013-12-04 00:21:10

Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute join together to launch Juno Therapeutics Inc. Company founded with $120M initial investment, among largest fully committed Series A for a biotech startup in history Juno to develop broad pipeline of potentially revolutionary cancer immunotherapy products NEW YORK and SEATTLE, Dec. 4, 2013 /PRNewswire-USNewswire/ -- The Fred Hutchinson Cancer Research...

Breast Cancer Risk From High Cholesterol
2013-11-30 04:57:15

Rebekah Eliason for redOrbit.com - Your Universe Online Researchers have discovered a byproduct of cholesterol that functions similarly to the hormone estrogen and stimulates the growth and spread of common forms of breast cancer cells. Encouragingly, researchers also found that certain anti-cholesterol drugs, like statins, seem to reduce the harmful effects of the estrogen-like molecule. The researchers caution, however, that the study's findings are still early in their development....

2013-11-26 16:24:43

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the successful treatment of a child with recurrent diffuse intrinsic pontine gliosarcoma (DIPGGS) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Pediatric gliosarcoma (GS) is a rare variant of glioblastoma multiforme. The pontine location of this tumor is unusual, invariably fatal and successful treatment was not yet described in medical literature. The...

2013-11-26 08:27:27

Additional Preclinical Studies Demonstrate Potential for Intravenous Administration of Toca 511 and Use in Combination with Temozolomide and Radiation SAN DIEGO, Nov. 26, 2013 /PRNewswire/ -- Tocagen Inc. today announced that interim clinical data from two ongoing Phase I investigational studies presented at the Society for Neuro-Oncology (SNO) Annual Meeting in San Francisco showed that Toca 511 administration followed by courses of oral Toca FC was safe and well tolerated in 60...

2013-11-25 15:15:08

Glioblastoma is one of the most ominous brain tumors. Despite aggressive surgery, radiation and chemotherapy the outcome of this disease is almost always fatal. A UZH research team has now achieved success with a novel form of treatment that involves encouraging the body’s own immune system to recognise and eliminate cancer cells in the brain. Animal experiments show that it is relatively easy to treat cancer in the early stages. However, it is far more difficult to successfully treat...

2013-11-23 23:02:03

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his determination to embrace life despite his battle with brain cancer. New York, NY (PRWEB) November 23, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his will to live a full life despite his battle with brain cancer. According to a November 13, 2013 article published by ABC News titled...

2013-11-22 08:23:18

VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 22, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of interim data from a Phase 1/2 clinical trial for VAL-083 in recurrent glioblastoma (GBM) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO) being held in conjunction with the 18(th) Annual Society for Neuro-Oncology (SNO) meeting in San Francisco. Enrollment in the...

2013-11-14 13:07:51

EPFL researchers have shown that copper is essential for the energy production of malignant cells, and that reducing its intake via food and water can slow down tumor growth Copper imbalances have been associated with a number of pathological conditions, including cancer. Publishing in PNAS scientists at EPFL have found that copper in drinking water – given at the maximum levels permitted in public water supplies – accelerated the growth of tumors in mice. On the other hand, reducing...